RhumbLine Advisers
AMPE

RhumbLine Advisers’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

RhumbLine Advisers’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-548
Closed -$77K – 3324
2022
Q1 		$77K Buy
548
+62
+13% +$9.05K ﹤0.01% 2936
2021
Q4 		$83K Sell
486
-14
-3% -$5.22K ﹤0.01% 2956
2021
Q3 		$249K Buy
500
+30
+6% +$13.9K ﹤0.01% 2841
2021
Q2 		$235K Buy
+470
New +$252K ﹤0.01% 2877
2019
Q2 		– Sell
-366
Closed -$62K – 3031
2019
Q1 		$62K Sell
366
-7
-2% -$1.2K ﹤0.01% 2907
2018
Q4 		$44K Buy
373
+132
+55% +$20.3K ﹤0.01% 2952
2018
Q3 		$37K Buy
241
+8
+3% +$3.34K ﹤0.01% 2913
2018
Q2 		$154K Buy
+233
New +$174K ﹤0.01% 2800
2017
Q2 		– Sell
-121
Closed -$29K – 2975
2017
Q1 		$29K Buy
121
+8
+7% +$2.15K ﹤0.01% 2836
2016
Q4 		$31K Sell
113
-36
-24% -$8.57K ﹤0.01% 2841
2016
Q3 		$33K Buy
149
+4
+3% +$1.12K ﹤0.01% 2857
2016
Q2 		$56K Buy
+145
New +$158K ﹤0.01% 2959
2015
Q2 		– Sell
-134
Closed -$303K – 3117
2015
Q1 		$303K Buy
134
+26
+24% +$44.3K ﹤0.01% 2608
2014
Q4 		$111K Buy
108
+3
+3% +$3.21K ﹤0.01% 2946
2014
Q3 		$111K Buy
105
+1
+1% +$1.68K ﹤0.01% 2917
2014
Q2 		$261K Buy
104
+27
+35% +$55.1K ﹤0.01% 2680
2014
Q1 		$146K Sell
77
-4
-5% -$9.46K ﹤0.01% 2861
2013
Q4 		$173K Buy
81
+1
+1% +$2.36K ﹤0.01% 2864
2013
Q3 		$180K Sell
80
-1
-1% -$1.93K ﹤0.01% 2820
2013
Q2 		$140K Buy
+81
New +$129K ﹤0.01% 3151

Other funds holding AMPE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $3.54B AUM 19.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RhumbLine Advisers's AMPE Position: Q2 2022 in Review

RhumbLine Advisers sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q2 2022, closing a stake of 548 shares — an estimated $77K sold.

RhumbLine Advisers first reported a position in AMPE in Q2 2013 and held it in 20 quarters. The position peaked at $303K in Q1 2015. 111 funds tracked by Wall St. Rank hold AMPE as of Q2 2022.

  • RhumbLine Advisers reported no remaining Ampio Pharmaceuticals Inc. position as of Q2 2022 after selling out during the quarter.
  • RhumbLine Advisers sold 548 Ampio Pharmaceuticals Inc. shares in Q2 2022, an estimated $77K.
  • RhumbLine Advisers first reported a position in Ampio Pharmaceuticals Inc. in Q2 2013 and held it in 20 quarters.
  • RhumbLine Advisers's Ampio Pharmaceuticals Inc. position peaked at $303K in Q1 2015.
  • 111 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q2 2022.

Based on RhumbLine Advisers's 13F filing for Q2 2022, filed 11 Aug 2022.